Dr Rovel Colaco, Consultant Clinical Oncologist

Dr Rovel Colaco

Consultant Clinical Oncologist

Book online

Dr Rovel Colaco BsC Hons, MB ChB, MRCP, FRCR

Consultant Clinical Oncologist


Dr Rovel Colaco

Consultant Clinical Oncologist BsC Hons, MB ChB, MRCP, FRCR

Book online

Areas of expertise

  • Primary brain tumours
  • Stereotactic radiosurgery (SRS)
  • Brain metastasis
  • Proton therapy
  • Oligo-metastases


  • The Christie Private Care

    Wilmslow Road, Manchester, M20 4BX

About Dr Rovel Colaco

GMC number: 6026485

Year qualified: 2001

Place of primary qualification: University of Glasgow

Dr Colaco: Leading Clinical Oncologist Specialising in Proton and Stereotactic Radiotherapy

Dr Colaco is a distinguished clinical oncologist at The Christie, renowned for his expertise in proton therapy and stereotactic radiotherapy. He trained in clinical oncology at The Christie before becoming the first UK doctor selected to train in proton therapy.

Dr Colaco spent 12 months at the University of Florida Proton Therapy Institute, where he honed his skills in proton therapy. He then completed a year at Yale University in Connecticut, USA, as the first graduate of Yale's Stereotactic Radiotherapy fellowship. During his time at Yale, he specialised in stereotactic radiosurgery (SRS) for brain metastases and extra-cranial stereotactic radiotherapy (SABR), utilising both Gamma Knife and CyberKnife technology.

An accomplished author, Dr Colaco has published several peer-reviewed manuscripts on stereotactic radiotherapy and proton therapy in international journals. He is also a sought-after speaker, having been invited to present at numerous international conferences on these subjects.

Upon his return to The Christie, Dr Colaco was appointed to a leading role in both the proton therapy and stereotactic radiotherapy programmes. He treats primary brain and spine tumours with both proton and X-ray therapy, and manages brain, bone, lymph node, and spinal metastases with stereotactic radiotherapy.

Dr Colaco is currently the co-chair for CNS and skull base tumours of the Particle Therapy Co-operative Group (PTCOG), which spearheads the development of proton therapy for brain and spine tumours worldwide. Additionally, as a member of the UK SABR consortium committee, he plays a pivotal role in advancing stereotactic radiotherapy (SABR) for spine and bone tumours nationally.

Dr Colaco's dedication to his field and his pioneering work in advanced radiotherapy techniques make him a leading figure in clinical oncology, both in the UK and internationally.

Professional memberships

Royal College of Physicians
Royal College of Radiologists
General Medical Council

Articles by Dr Rovel Colaco

Results of a pilot/phase ii study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials

Radiation necrosis – a growing problem in a case of brain metastases following whole brain radiotherapy and stereotactic radiosurgery

The effect of dose and other parameters on outcomes in cyberknife stereotactic radiosurgery for trigeminal neuralgia

Bm-10 * systemic treatment and radiation necrosis following gksrs in the treatment of brain metastases

Spine stereotactic body radiation therapy outcomes in patients with concurrent brain metastases

Spine stereotactic body radiotherapy outcomes in patients with concurrent brain metastases